Poly Medicure Limited has announced its audited financial results for the quarter and financial year ended March 31, 2026. The Board of Directors has recommended a final dividend of ₹3.50 per equity share (70%) for the financial year 2025-26. The company continues to show robust growth, supported by strategic acquisitions and operational expansion. The results reflect the company’s commitment to delivering value to its shareholders alongside sustained business development.
Annual Financial Performance
For the financial year ended March 31, 2026, Poly Medicure Limited reported a strong financial performance. On a consolidated basis, the company achieved total income of ₹1,95,534.14 lakh for the year. The profit after tax for the same period stood at ₹32,072.99 lakh, reflecting the company’s sustained operational efficiency and market presence.
Dividend Declaration
Recognizing the company’s performance, the Board of Directors has recommended a dividend of ₹3.50 per equity share of face value ₹5 each for the financial year 2025-26. This dividend payout of 70% is subject to the approval of shareholders in the upcoming annual general meeting.
Strategic Growth and Acquisitions
During the fiscal year, the company focused on inorganic growth through strategic acquisitions, including the Pendracare Group and the Citeffe Group. These acquisitions are part of the company’s long-term strategy to expand its international footprint and strengthen its product portfolio. The management noted that the initial accounting for these business combinations has been provisionally recognized in the consolidated financial statements.
Audit and Governance
The company successfully concluded its board meeting on May 25, 2026, during which it also approved the re-appointment of PricewaterhouseCoopers Services LLP and M/s Oswal Sunil & Co. as internal auditors for the financial year 2026-27. The statutory auditors have issued an un-modified audit opinion on both the standalone and consolidated financial results for the quarter and year ended March 31, 2026.
Source: BSE
